⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14829196 | 0.72 | POLB (0.31) | — | |
| SCHEMBL24711969 | 0.70 | EPRS1 (0.38) | — | |
| SCHEMBL20704188 | 0.69 | CHRNB2 (0.32) | — | |
| SCHEMBL16913805 | 0.68 | PIK3C3 (0.35) | — | |
| SCHEMBL31229804 | 0.67 | CHRNB2 (0.31) | — | |
| SCHEMBL26685313 | 0.67 | NQO2 (0.32) | — | |
| SCHEMBL217854 | 0.66 | — | — | |
| SCHEMBL29364685 | 0.66 | — | — | |
| SCHEMBL21899162 | 0.65 | CCR1 (0.43) | — | |
| SCHEMBL25220576 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250276968-A1 | 8- AND 6-SUBSTITUTED PYRIDOPYRIMIDINE DERIVATIVES AS KRAS INHIBITORS | BETA PHARMA, INC. | 2025-09-04 | — | — | US | disclosed |
| EP-4522614-A1 | 8- AND 6-SUBSTITUTED PYRIDOPYRIMIDINE DERIVATIVES AS KRAS INHIBITORS | Beta Pharma, Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| CN-119156387-A | 8-Substituted and 6-substituted pyridopyrimidine derivatives as KRAS inhibitors | 贝达医药公司 | 2024-12-17 | — | — | CN | disclosed |
| WO-2023219941-A1 | 8- AND 6-SUBSTITUTED PYRIDOPYRIMIDINE DERIVATIVES AS KRAS INHIBITORS | BETA PHARMA, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023219941-A1 | 8- AND 6-SUBSTITUTED PYRIDOPYRIMIDINE DERIVATIVES AS KRAS INHIBITORS | BETA PHARMA, INC. (US) | 2023-11-16 | — | — | WO | disclosed |